Quantcast

Latest OSI Pharmaceuticals Stories

2011-01-10 07:10:00

TOKYO, Jan. 10, 2011 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503) announced today that it has engaged Citigroup Global Markets Inc. to conduct, in conjunction with executive management, a review of the Company's strategic alternatives with regard to its Prosidion subsidiary.

2010-06-09 02:42:00

TOKYO, June 9 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503) announced today that the company has completed its acquisition of OSI Pharmaceuticals, Inc.

2010-03-30 23:14:00

TOKYO, March 31 /PRNewswire/ -- Astellas Pharma Inc.

2010-03-15 13:18:00

TOKYO, March 15 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503) today released the following statement in response to OSI Pharmaceuticals' (Nasdaq: OSIP) rejection of Astellas' tender offer for $52.00 per share.

2010-03-01 05:05:00

TOKYO, March 1 /PRNewswire-FirstCall/ -- Astellas Pharma Inc.

2010-02-22 06:00:00

CAMBRIDGE, Mass., Feb. 22 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. announced today that the first patient has received an initial dose in a Phase 1/2 clinical study combining MM-121 with Tarceva(®) (erlotinib) in patients with non-small cell lung cancer (NSCLC).


Word of the Day
honeyguide
  • Any of various tropical Old World birds of the family Indicatoridae, some species of which lead people or animals to the nests of wild honeybees. The birds eat the wax and larvae that remain after the nest has been destroyed for its honey.
Honeyguide birds have even been known to eat candles.